NOCD key facts
- Developer of a telehealth application designed to assist in the self-treatment and monitoring of obsessive-compulsive disorder symptoms.
- NOCD’s last known valuation is $268.7M.
- It has raised $90.0M; the latest was Later Stage VC ($5.7M) in Aug 2024.
- Notable investors include F-Prime Capital, Eight Roads, Hyde Park Angels, Longitude Capital, Chicago Ventures — 16 tracked in total.
- Status: Privately Held (backing).
Who backs NOCD
16+- ·The complete investor list: 16 names
- ·Watch NOCD: the Monday email on marks, rounds and moves
NOCD funding rounds
No funding rounds for NOCD are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
NOCD valuation
NOCD's last known valuation is $269 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
NOCD investors
16 investors are on record for NOCD, including F-Prime Capital, Eight Roads, Hyde Park Angels and Longitude Capital. By type, the record holds 5 venture capital firms, 1 family office and 1 asset manager.
About NOCD
Developer of a telehealth application designed to assist in the self-treatment and monitoring of obsessive-compulsive disorder symptoms. The company's application guides patients through exposure and response prevention exercises and therapy that is especially effective for obsessive-compulsive disorder, enabling clinicians and researchers to improve obsessive-compulsive disorder treatment and connect with patients.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2014
- Employees
- 475
- Website
- treatmyocd.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
NOCD’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.